Home Page
About us
Guangzhou KOFA Biotechnology Co.,Ltd. was founded in 2004, headquartered in Guangzhou High-tech Industry Development Zone, Science City. KOFA Biotech focuses on the research and development, manufacturing, sales and service of In Vitro Diagnostic (IVD) reagent and instrument, adhering to the concept, science and technology benefit everyone, to provide perfect quantity-value solutions and services for clinical medical diagnosis.
News Center
Compared with traditional IVD products, POCT has three major advantages: short test time, wide detection space, and easy operation. It can meet the needs of fast and timely testing, and has become a revolutionary and rapidly developing sub field in the IV
More+Products
Service Support
KOFA consistently adhere to the principle of "profession,strictness and preciseness" as the professional provider of high-quality and reliable products as well as close-to-customer service for the world. KOFA proficient and excellent engineering team is always ready to provide top service and professional technological support in the shortest time. Sincerely provide better and better service for all the customers.
Contact us
2024-12-02 Kefang News
Review of "Gathering power and win-win" event
On November 25, the "2024 First Medical Alliance New Ecology Conference & Zhejiang Medical Channel Sharing and Resource Docking Conference", sponsored by the League of Nations Medical Industry Alliance, was successfully held in Hangzhou, Zhejiang Province. With the theme of "Gathering momentum and win-win", this event focused on the reform and future development trend of medical charging projects. Under the background of medical reform, the conference aims to build a platform for medical manufacturers to exchange, cooperate and seek common development, jointly explore the new direction of the future development of the medical industry, promote channel sharing, resource docking, gather all parties to achieve win-win cooperation!
KOFA V919 ultra-high speed chemiluminescence brilliant appearance
KOFA Biological brought V919 ultra-high speed automatic chemiluminescence immunoanalyzer to this event, and showed the product to many participating customers in an all-round way, and conducted an in-depth application demonstration. Through this face-to-face communication, KOFA Biological not only deepened the interaction with customers, but also successfully attracted the attention of many on-site participants, stimulated their strong interest in V919 products, strengthened the product image of KOFA biological in the field of ultra-high-speed chemiluminescence, and highlighted its leading position in the field and technological innovation ability.
KOFA Biological V919 ultra-high speed automatic chemiluminescence immunoanalyzer single module up to 800T/H, covers an area of only 1.73m2, the first test results within 9 minutes, support automatic uncapping, automatic dilution, intelligent retest, random, batch, emergency detection mode and other practical functions, effectively solve the clinical laboratory pain points and difficulties. Comprehensively improve the quality of inspection.
V919 not only has fast detection speed, but also has flexible expansion functions, which can support a maximum of 4 V919 cascades, but also can be cascaded with biochemical analyzers to form ultra-high speed generation and free pipeline, greatly improving detection efficiency.
Future outlook
The "2024 First Medical Alliance New Ecological Conference and Zhejiang Medical Channel Sharing and Resource Docking Conference" provides an excellent stage for enterprises in the medical and health field to display innovative achievements and deepen cooperation. With the help of this event, Kefang Biological not only strengthened the exchanges and cooperation with the industry inside and outside, but also gained a deeper insight into the market demand and the development trend of the industry. We firmly believe that through continuous technological innovation and market expansion, KOFang Bio will make significant contributions to promoting the high-quality development of the healthcare industry.